Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
InspireMD ( (NSPR) ) just unveiled an announcement.
InspireMD announced the upcoming retirement of its Chief Financial Officer, Craig Shore, after a successor is appointed. Shore, who has contributed significantly to the company’s growth over 15 years, will aid in the transition process. This leadership change comes as the company is poised for potential FDA approval in 2025 and is intensifying its focus on the investment community. InspireMD has initiated a search for a new CFO to continue its trajectory as a global leader in carotid interventions.
More about InspireMD
InspireMD, Inc., traded on Nasdaq under the ticker symbol NSPR, is a developer of the CGuard™ Embolic Prevention Stent System (EPS) aimed at preventing strokes. The company utilizes its proprietary MicroNet® technology to set industry standards in carotid stenting, providing stroke-free long-term outcomes.
YTD Price Performance: 12.81%
Average Trading Volume: 42,602
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $82.69M
Learn more about NSPR stock on TipRanks’ Stock Analysis page.
